Sign inJoin waitlistJoin the waitlist

Paul Harker-Murray

Medical Director of the Clinical Trials Office Children's Wisconsin · Children's Wisconsin - Fox Valley

Credentials: · · · · ·

History

Clinical Trials Office Children's Wisconsin · Children's Wisconsin - Fox Valley
Present
Medical College of Wisconsin Affiliated Hospitals, Inc
Present
Children's Wisconsin - Fox Valley
Present

Hematology and Medical Oncology
University of Minnesota
2004–2007
Pediatrics
University of Minnesota
2001–2004
2001, Mayo Graduate School of Medicine, PhD
Mayo Clinic Alix School of Medicine
1997–2001

Research

Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma
Journal of Clinical Oncology · 2022 · 138 citations
Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting…
Blood · 2008 · 124 citations
Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple…
Brain · 2000 · 109 citations

Kara Kelly
5 papers
Brad Hoppe
4 papers
MR
Moses Rodriguez
4 papers
Peter Cole
4 papers
Richard Drachtman
4 papers
CF
Christopher Forlenza
3 papers
CE
Craig Erker
3 papers
Justine Kahn
3 papers
Patrick Zweidler-McKay
3 papers
RH
Robert Hayashi
3 papers
Rodney Miles
3 papers
Steve Cho
3 papers

Clinical trials

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Study chair · Unknown · Phase 1
South Plains Oncology Consortium
2013–2023
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
Project: Every Child for Younger Patients With Cancer
Site PI · Recruiting
Children's Oncology Group
2015–2030